Meter Maker Settles Suit


By: Daniel Trecroci

Blood-glucose meter maker LifeScan agreed on November 26, 2001, to pay $45 million to hundreds of thousands of people with diabetes—avoiding a trial that was set to begin that week.

According to Howard Mintz of the San Jose Mercury News, the settlement resolved a nationwide class-action lawsuit filed on behalf of consumers who purchased LifeScan’s SureStep blood-glucose meter. In 2000, LifeScan pleaded guilty to misdemeanor charges involving defects in the SureStep meter that it allegedly knew about but failed to disclose to consumers or to the U.S. Food and Drug Administration.

Under the conditions of the settlement, LifeScan admits no wrongdoing. “In the past, LifeScan, while conceding that it made mistakes, has strongly denied intentionally marketing a defective product and causing any harm to people with diabetes who used the SureStep device, which has been upgraded and remains on the market,” according to the Mercury News article.

The settlement was announced in San Jose Federal Court.



Diabetes Health Medical Disclaimer
The information on this site is not intended or implied to be a substitute for professional medical advice, diagnosis or treatment. All content, including text, graphics, images, and information, contained on or available through this website is for general information purposes only. Opinions expressed here are the opinions of writers, contributors, and commentators, and are not necessarily those of Diabetes Health. Never disregard professional medical advice or delay seeking medical treatment because of something you have read on or accessed through this website.